Amyloidosis
📧 Sign up to get email alerts when something new happens for Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-10-26Clinical Trial Update: Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
A clinical trial studying prospective identification of cardiac amyloidosis using cardiac magnetic resonance imaging has been withdrawn.
-
EMA withdrawal · 2008-03-17EMA Application withdrawn: Kiacta (eprodisate disodium) — Neurochem Luxco II SARL
EMA withdrew the application for Kiacta (eprodisate disodium) in the treatment area of amyloidosis.